Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-09-19 00:00:00 ET · period of report 2025-09-17 · accession 0001773751-25-000311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2025-09-17 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale | $50.57 | -65.1K | 95.3K | -41% | -$3.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-09-17 | S | D | 65,110 | $50.57 | 95,315 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.06 - $50.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |